arrow
H

Hiroshi Onishi

University of Yamanashi
H指数:43
被引数:8,877

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

2026-09-290
OAAI
Clinical practice, barriers to implementation, and priorities for equitable access of Stereotactic Body Radiation Therapy: An analysis of the global status by the ESTRO SBRT Focus Group

立体定向体部放射治疗(Stereotactic Body Radiation Therapy)的临床实践、实施障碍以及公平获取的优先事项:ESTRO SBRT Focus Group 对全球现状的分析

2025-12-140
OAAI
National survey on definitive radiotherapy practices for locally advanced non-small cell lung cancer in Japan: JROSG 23-3

日本对局部晚期非小细胞肺癌的确定性放射治疗实践的全国调查: JROSG 23-3

2025-11-010
PRE
Efficacy of Stereotactic Ablative Body Radiotherapy (SABR) in uncommon subtypes of primary kidney cancer: An analysis from the International Radiosurgery Oncology Consortium of the Kidney

立体定向消融体部放射治疗(SABR)在不常见类型原发性肾癌中的疗效:国际肾脏放射外科肿瘤学协作组(International Radiosurgery Oncology Consortium of the Kidney)的分析

2025-09-020
PRE
Evaluation of weight loss and improvement of steatotic liver disease using magnetic resonance imaging in patients with metabolic dysfunction associated steatotic liver disease

磁共振成像评价代谢功能障碍相关脂肪性肝病患者体重减轻和脂肪性肝病改善情况

2025-01-210
OA
Long-term Renal Function Outcomes After Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma Including Patients with a Solitary Kidney: A Report from the International Radiosurgery Oncology Consortium of the Kidney

包括孤立肾患者在内的原发性肾细胞癌立体定向消融放疗后的长期肾功能预后: 国际肾脏放射外科肿瘤学联合会的报告

2024-12-013
PRE
Effect of a combination of pemafibrate and a mild low-carbohydrate diet on obese and non-obese patients with metabolic-associated fatty liver disease
2023-03-056
OAAI